That sure would be nice!
> On Jun 15, 2019, at 1:09 PM, Lorraine Johnston <johnston1...@comcast.net> > wrote: > > Perhaps there will be additional funding for FeLV research resulting from > this change. > > - Lorraine > > > If your email program has trouble displaying this email, view it as a web > page > <http://s2027422842.t.en25.com/e/es?s=2027422842&e=224317&elqTrackId=376c7bc788024cd5a73d955f2e3dcbdc&elq=1178abce339c494f9a140e6add5496c1&elqaid=8386&elqat=1>. > > > > > > FDA Increases Total Individual Award Amount for Minor Use/Minor Species Grants > > > Application period opens June 14, 2019 > > The U.S. Food and Drug Administration today announced an open period for > applications for grants to support the development and approval or > conditional approval of new animal drugs intended to treat uncommon diseases > (minor uses) in major species (horses, dogs, cats, cattle, pigs, turkeys and > chickens) or to treat minor species (MUMS). The individual award amount has > been increased to a single funding level up to $250,000. > > The Minor Use and Minor Species Animal Health Act of 2004 (the MUMS act) > provides innovative ways to bring products to market for these small > populations and is designed to help veterinary pharmaceutical companies and > others overcome the financial roadblocks they face in providing animal drugs > for a limited market. Before this legislation, veterinary pharmaceutical > companies and others would rarely attempt to bring such drugs to market. The > MUMS act established the grant program. > > Grants awarded through the MUMS program support the FDA’s continuing mission > to assure that safe and effective animal drugs are available for a wide range > of species and conditions. > > > Read more > <http://s2027422842.t.en25.com/e/er?utm_campaign=6-14-2019-MUMSGrants&utm_medium=email&utm_source=Eloqua&s=2027422842&lid=8353&elqTrackId=3C91C3300655917EA59D591D87437846&elq=1178abce339c494f9a140e6add5496c1&elqaid=8386&elqat=1> > > > > > <http://s2027422842.t.en25.com/e/er?utm_campaign=6-14-2019-MUMSGrants&utm_medium=email&utm_source=Eloqua&s=2027422842&lid=11&elqTrackId=EC8FB39F90BA0488B8C1A2FBF2A765FF&elq=1178abce339c494f9a140e6add5496c1&elqaid=8386&elqat=1> > U.S. Food and Drug Administration > 10903 New Hampshire Avenue, Silver Spring, MD 20993 > 1-888-INFO-FDA (1-888-463-6332) > Privacy Policy > <https://www.fda.gov/AboutFDA/AboutThisWebsite/WebsitePolicies/default.htm?utm_campaign=6-14-2019-MUMSGrants&utm_medium=email&utm_source=Eloqua&elqTrackId=97465b0f8e0047fa991a1d069a1619aa&elq=1178abce339c494f9a140e6add5496c1&elqaid=8386&elqat=1&elqCampaignId=6888#privacy> > | www.fda.gov > <https://www.fda.gov/?utm_campaign=6-14-2019-MUMSGrants&utm_medium=email&utm_source=Eloqua&elqTrackId=23294b99d9404d5b81de0b3a0999c2af&elq=1178abce339c494f9a140e6add5496c1&elqaid=8386&elqat=1&elqCampaignId=6888> > > > > _______________________________________________ > Felvtalk mailing list > Felvtalk@felineleukemia.org <mailto:Felvtalk@felineleukemia.org> > http://felineleukemia.org/mailman/listinfo/felvtalk_felineleukemia.org > <http://felineleukemia.org/mailman/listinfo/felvtalk_felineleukemia.org>
_______________________________________________ Felvtalk mailing list Felvtalk@felineleukemia.org http://felineleukemia.org/mailman/listinfo/felvtalk_felineleukemia.org
